FDA Approved a Total of 39 New Drugs in 2012 – Fifteen Year High

RDInvesting Provides Stocks Research on ACADIA Pharmaceuticals and Discovery Laboratories

Continue Reading

High Yielding REITs Outperform Broader S&P 500 Index for the Fourth Consecutive Year

Five Star Equities Provides Stock Research on Newcastle Investment and RAIT Financial Trust

Continue Reading

Activision Blizzard and Take-Two Interactive Rise on Strong Earnings — China Considers Lifting Ban on Game Consoles

Five Star Equities Provides Stock Research on Activision Blizzard and Take-Two Interactive

Continue Reading

Video Game Industry Could Receive a Boost as China Considers Lifting Ban on Video Game Consoles

Five Star Equities Provides Stock Research on Electronic Arts and Majesco Entertainment

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

RDInvesting Provides Stocks Research on Celldex Therapeutics and Peregrine Pharmaceuticals

Continue Reading

Centers for Medicare and Medicaid Services Projects Health Care Spending to Grow From $2.8 Trillion to $4.8 Trillion by 2021

Research Driven Investing Provides Stocks Research on Centene and Molina Healthcare

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

RDInvesting Provides Stocks Research on Alexza Pharmaceuticals and Savient Pharmaceuticals

Continue Reading

Advanced Energy Industries and MEMC Electronic Materials on the Upswing After Receiving “Buy” Rating from Citigroup.

RDInvesting Provides Stock Research on Advanced Energy Industries and MEMC Electronic Materials

Continue Reading

Improving Housing Market Continues to Boost Investor-s Appetite for High Yielding REITs

Five Star Equities Provides Stock Research on American Capital Mortgage and CYS Investments

Continue Reading

FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High

Research Driven Investing Provides Stocks Research on StemCells and ZIOPHARM Oncology

Continue Reading